Press Releases

  • CDEX Signs Agreement With HealthContrax LLC to Distribute the ValiMed™ Validation System, Gaining Access to National Group Purchasing Organizations

    January 7, 2011, by , Posted in Press Releases, Comments Off on CDEX Signs Agreement With HealthContrax LLC to Distribute the ValiMed™ Validation System, Gaining Access to National Group Purchasing Organizations

    TUCSON, AZ--(Marketwire - January 7, 2011) - CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today the signing of a new distribution agreement with HealthContrax LLC, an Iowa-based national accounts sales agency. The agreement provides CDEX with access to Group Purchasing Organizations (GPOs) that contract ...

  • CDEX Inc. Appoints Dr. James G. Stevenson to the CDEX Board of Directors

    December 20, 2010, by , Posted in Press Releases, Comments Off on CDEX Inc. Appoints Dr. James G. Stevenson to the CDEX Board of Directors

    TUCSON, AZ--(Marketwire - December 20, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced the appointment of Dr. James G. Stevenson to its Board of Directors. Dr. Stevenson has been the Director of Pharmacy Services at the University of Michigan Health system since ...

  • CDEX’s ValiMed G4 System Featured at the 45th Annual ASHP Midyear Conference

    December 7, 2010, by , Posted in Press Releases, Comments Off on CDEX’s ValiMed G4 System Featured at the 45th Annual ASHP Midyear Conference

    Fourth Generation ("G4") System Features Multi-Compound Measurement Capabilities TUCSON, AZ--(Marketwire - December 7, 2010) - CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced the Company will exhibit its proprietary ValiMed G4 multi-component medication and narcotic detection system, at the 45th Annual Midyear ASHP Clinical Meeting ...

  • Independent Testing of CDEX’s Improved ID2 Meth Scanner for Commercial and Home Inspection Surpasses State and National Standards

    December 1, 2010, by , Posted in Press Releases, Comments Off on Independent Testing of CDEX’s Improved ID2 Meth Scanner for Commercial and Home Inspection Surpasses State and National Standards

    TUCSON, AZ--(Marketwire - December 1, 2010) - CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced the positive results of a field test study of its improved ID2 Meth Scanner used for commercial and home property inspection. The new version of ID2 Meth Scanner has ...

  • CDEX Launches New Pocket ID2 Device and Receives First Purchase Order From Lifeloc Technologies

    November 10, 2010, by , Posted in Press Releases, Comments Off on CDEX Launches New Pocket ID2 Device and Receives First Purchase Order From Lifeloc Technologies

    TUCSON, AZ--(Marketwire - November 10, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com), a leading developer of chemical detection products, using patented technologies, for use in healthcare and security markets, announced today the launch of its new Pocket ID2 Scanner. CDEX also signed a distribution agreement with Lifeloc Technologies, a leading supplier of breath alcohol testers to law enforcement agencies, for ...

  • CDEX Announces New Management, New Focus and New Future

    September 16, 2010, by , Posted in Press Releases, Comments Off on CDEX Announces New Management, New Focus and New Future

    TUCSON, AZ--(Marketwire - September 16, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) -- We are pleased to announce that Jeff Brumfield has been appointed as the new Chairman of the Board and Chief Executive Officer of CDEX Inc. He brings back to the Company Dr. Wade Poteet as the Chief Science Officer who will be overseeing the development of ...

  • CDEX Inc. Appoints Donald W. Strickland as Its New CEO

    April 19, 2010, by , Posted in Press Releases, Comments Off on CDEX Inc. Appoints Donald W. Strickland as Its New CEO

    TUCSON, AZ--(Marketwire - April 19, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces that its Board of Directors has appointed Donald W. Strickland as its new CEO. Mr. Strickland, a Director of the Company, has served in senior management positions for over 30 years and has successfully developed businesses for both large public companies and technology startups. He has held ...

  • CDEX Inc Financial Restructuring Plan Achieving Results

    April 16, 2010, by , Posted in Press Releases, Comments Off on CDEX Inc Financial Restructuring Plan Achieving Results

    Financial Restructuring Plan Is Providing CDEX Stability for Continued Growth in 2010 TUCSON, AZ--(Marketwire - April 16, 2010) -  On February 19, 2010 CDEX announced it had entered into a Financial Restructuring Plan that immediately restructured certain existing debt into two year notes, with a provision for extending these notes to other creditors. Today, CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces ...

  • Five New Hospitals Order ValiMed™ MVS by CDEX to Protect Patients

    April 14, 2010, by , Posted in Press Releases, Comments Off on Five New Hospitals Order ValiMed™ MVS by CDEX to Protect Patients

    TUCSON, AZ--(Marketwire - April 14, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces it has received five orders for ValiMed™ Medication Validation Systems (MVS) from new hospital clients in states including Illinois, Pennsylvania, Florida, and Colorado. Studies worldwide continue to show high numbers of mistakes in the compounding of high-risk medications resulting in substantial harm to patients and economic ...

  • Medication Safety and Narcotic Diversion Prevention Equipment Showcased by CDEX at HCP

    April 12, 2010, by , Posted in Press Releases, Comments Off on Medication Safety and Narcotic Diversion Prevention Equipment Showcased by CDEX at HCP

    TUCSON, AZ--(Marketwire - April 12, 2010) -  CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces demonstration of its ValiMed™ Medication Validation System (MVS) to Directors of Pharmacy at the Health Connect Partners (HCP) Reverse Expo in San Diego, CA on April 12-14. Studies worldwide continue to show unacceptable frequency of mistakes in the compounding of high-risk medications resulting in substantial harm ...